JP2007522178A5 - - Google Patents

Download PDF

Info

Publication number
JP2007522178A5
JP2007522178A5 JP2006552575A JP2006552575A JP2007522178A5 JP 2007522178 A5 JP2007522178 A5 JP 2007522178A5 JP 2006552575 A JP2006552575 A JP 2006552575A JP 2006552575 A JP2006552575 A JP 2006552575A JP 2007522178 A5 JP2007522178 A5 JP 2007522178A5
Authority
JP
Japan
Prior art keywords
methyl
oxy
benzothien
acetic acid
trifluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006552575A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007522178A (ja
Filing date
Publication date
Priority claimed from GBGB0403148.0A external-priority patent/GB0403148D0/en
Application filed filed Critical
Publication of JP2007522178A publication Critical patent/JP2007522178A/ja
Publication of JP2007522178A5 publication Critical patent/JP2007522178A5/ja
Pending legal-status Critical Current

Links

JP2006552575A 2004-02-12 2005-02-10 心臓血管疾患の治療に有用なベンゾフランおよびベンゾチオフェン誘導体 Pending JP2007522178A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0403148.0A GB0403148D0 (en) 2004-02-12 2004-02-12 Chemical compounds
PCT/EP2005/001540 WO2005077926A2 (en) 2004-02-12 2005-02-10 Benzofuran and benzothiophene derivatives useful for the treatment of cardiovascular disease

Publications (2)

Publication Number Publication Date
JP2007522178A JP2007522178A (ja) 2007-08-09
JP2007522178A5 true JP2007522178A5 (enExample) 2007-11-15

Family

ID=32011809

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006552575A Pending JP2007522178A (ja) 2004-02-12 2005-02-10 心臓血管疾患の治療に有用なベンゾフランおよびベンゾチオフェン誘導体

Country Status (8)

Country Link
US (1) US20070155805A1 (enExample)
EP (1) EP1740568B1 (enExample)
JP (1) JP2007522178A (enExample)
AT (1) ATE415395T1 (enExample)
DE (1) DE602005011267D1 (enExample)
ES (1) ES2317192T3 (enExample)
GB (1) GB0403148D0 (enExample)
WO (1) WO2005077926A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4917018B2 (ja) * 2004-05-03 2012-04-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 選択的アンドローゲン受容体モジュレーター(sarms)としての新規インドール化合物
TWI359810B (en) * 2004-11-04 2012-03-11 Mitsubishi Tanabe Pharma Corp Carboxylic acid derivative containing thiazole rin
WO2006101454A1 (en) * 2005-03-21 2006-09-28 S*Bio Pte Ltd Benzothiophene derivatives: preparation and pharmaceutical applications
RU2435764C2 (ru) 2006-04-18 2011-12-10 Ниппон Кемифар Ко., Лтд. АГЕНТ, АКТИВИРУЮЩИЙ РЕЦЕПТОР, АКТИВИРУЕМЫЙ ПРОЛИФЕРАТОРАМИ ПЕРОКСИСОМ δ
US20090163481A1 (en) * 2007-12-13 2009-06-25 Murphy Brian J Ppar-delta ligands and methods of their use
AU2009236877B2 (en) 2008-04-15 2014-01-23 Nippon Chemiphar Co., Ltd. Activator for peroxisome proliferator-activated receptor
KR20120099378A (ko) * 2009-08-14 2012-09-10 닛뽕 케미파 가부시키가이샤 염증 또는 에너지 대사/생산 관련 질환의 치료 또는 예방을 위한 ppar 델타 리간드의 용도
JP5929482B2 (ja) * 2011-05-10 2016-06-08 住友化学株式会社 植物の生長を促進する方法
JP5929483B2 (ja) * 2011-05-10 2016-06-08 住友化学株式会社 植物の生長を促進する方法
CN111393405B (zh) * 2019-01-02 2022-11-25 中国科学院上海药物研究所 一类含氟取代的苯并噻吩类化合物及其药物组合物及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859051A (en) * 1996-02-02 1999-01-12 Merck & Co., Inc. Antidiabetic agents
WO1997028149A1 (en) * 1996-02-02 1997-08-07 Merck & Co., Inc. Method for raising hdl cholesterol levels
CA2244831A1 (en) * 1996-02-02 1997-08-07 John T. Olson Method of treating diabetes and related disease states
AU719663B2 (en) * 1996-12-23 2000-05-11 Merck & Co., Inc. Antidiabetic agents
JP2003520838A (ja) * 2000-01-28 2003-07-08 ノボ ノルディスク アクティーゼルスカブ 新規化合物、それらの製造および使用。
JP2001261674A (ja) * 2000-03-22 2001-09-26 Mitsui Chemicals Inc ベンゾチオフェン誘導体およびそれを有効成分として含有する核内レセプター作動薬
GB0111523D0 (en) * 2001-05-11 2001-07-04 Glaxo Group Ltd Chemical compounds
US6875780B2 (en) * 2002-04-05 2005-04-05 Warner-Lambert Company Compounds that modulate PPAR activity and methods for their preparation
CA2491733A1 (en) * 2002-07-30 2004-02-05 Merck & Co., Inc. Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
ES2344106T3 (es) * 2002-10-28 2010-08-18 High Point Pharmaceuticals, Llc Nuevos compuestos utiles en el tratamiento de enfermedades mediadas por ppar.

Similar Documents

Publication Publication Date Title
JP2004534035A5 (enExample)
JP2004520377A5 (enExample)
JP2004518702A5 (enExample)
ES2240558T3 (es) Derivados de tiazol y oxazol como activadores de receptores activados por el proliferador de peroxisoma humano.
KR101179087B1 (ko) 인간 단백질 티로신 포스파타아제 억제제 및 이용 방법
JP2004529174A5 (enExample)
JP2007502806A5 (enExample)
ZA200100983B (en) Substituted oxazoles and thiazoles derivatives as hPPAR gamma and hPPAR alpha activators.
JP2007511485A5 (enExample)
ZA200308352B (en) Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors.
JP2009520769A5 (enExample)
JP2005529965A5 (enExample)
JP2007522178A5 (enExample)
JP2005528348A5 (enExample)
JP2004517100A5 (enExample)
JP2005505616A5 (enExample)
JP2006500384A5 (enExample)
JP2007520471A5 (enExample)
JP2005529077A5 (enExample)
ZA200109804B (en) Thiazole and oxazole derivatives and their pharmaceutical use.
JP2009541269A5 (enExample)
JP2013519680A5 (enExample)
PE20080360A1 (es) Derivados 4-bencilftalazinona 2-sustituidos como antagonistas de histaminas h1 y h3
JP2007502264A5 (enExample)
RU2019121871A (ru) Новые производные фенилпропионовой кислоты и их применение